{
  "ptid_time": "027_S_2336_2015-04-14",
  "img_path": "/data/qiuhui/data/adni/images/027_S_2336/2015-04-14/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,363 mm³, 10.6% below the reference mean. With a Z-score of -0.97 (16.6th percentile), this represents normal volume ; whole brain volume measures 828,182 mm³, 15.0% below the reference mean. With a Z-score of -1.89 (2.9th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,446 mm³, 6.2% below the reference mean. With a Z-score of -0.38 (35.2th percentile), this represents normal volume ; fusiform gyrus volume measures 13,885 mm³, 18.4% below the reference mean. With a Z-score of -1.67 (4.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 13,897 mm³, 27.5% below the reference mean. With a Z-score of -2.39 (0.8th percentile), this represents significant atrophy. ",
  "text_data": "Age is 76.9 years. Gender is Female. Education: 12 years. MMSE: 26.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.54 SUVR (profound elevated); Amyloid beta: 787.90 pg/mL (normal ); Total tau: 350.40 pg/mL (mild elevated); Phosphorylated tau: 35.78 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the middle temporal gyrus and moderate atrophy in the whole brain and fusiform gyrus, alongside normal hippocampal and entorhinal cortex volumes. Cognitive testing (MMSE 26, MoCA 21) suggests mild impairment, while biomarkers (elevated T-tau, P-tau, and AV45) indicate amyloid pathology despite normal Aβ.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker profile).  \n**Confidence:** **Medium** (atypical Aβ-normal result with tau/AV45 elevation complicates certainty, but structural and cognitive data align with MCI).",
  "timestamp": "2025-07-26T03:56:17.840529"
}